Oseaspre Consultants Shareholders Approve 5 Lakh Share Preferential Issue at Rs 48

OTHER
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Oseaspre Consultants Shareholders Approve 5 Lakh Share Preferential Issue at Rs 48

Oseaspre Consultants Ltd has secured 100% shareholder approval at its recent EGM to issue 5,00,000 equity shares at Rs 48 per share. The company will also increase its authorized share capital to accommodate this expansion. The move marks a significant capital infusion effort, with funds raised from non-promoters on a preferential basis.

Oseaspre Consultants Clears Preferential Issue of 5 Lakh Shares

  • Equity Issue: 5,00,000 shares approved at Rs 48 per share
  • Voting Support: 100% approval from shareholders for both special resolutions

Reader Takeaway: Shareholders backed a significant equity expansion; focus now shifts to allotment details and fund utilization strategies.

What just happened

Oseaspre Consultants Ltd held its first Extra-Ordinary General Meeting (EGM) for the 2026-2027 fiscal year on October 30, 2026. Shareholders unanimously passed two special resolutions. The first resolution authorizes an increase in the company's authorized share capital and corresponding changes to the Memorandum and Articles of Association. The second resolution approves the issuance of up to 5,00,000 equity shares on a preferential basis to non-promoters at a price of Rs 48 per share.

Why this matters

The preferential issue is a critical step for the company's capital structure. With a current paid-up base of 2,00,000 shares, the addition of 5,00,000 shares represents a major expansion. This cash-based infusion from non-promoters is expected to strengthen the balance sheet. Investors should look for regulatory disclosures regarding the identity of the allottees and the specific business objectives for which these funds will be deployed.

Voting Overview

The EGM saw participation from 13 members who cast their votes via remote e-voting, representing 82.92% of the total paid-up share capital. The process was overseen by Scrutinizer CS Nuren Nirmal Lodaya, who confirmed that the meeting complied with all relevant provisions of the Companies Act, 2013, and SEBI regulations.

What to track next

Shareholders should monitor subsequent filings for the final allotment report and the timeline for the infusion of funds. Understanding the long-term impact on earnings per share (EPS) and equity dilution will be essential for assessing future valuation.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.